Need professional-grade analysis? Visit stockanalysis.com
$921.96M
N/A
N/A
N/A
Inventiva S.A (IVEVF) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $5.75, up 4.55% from the previous close.
Over the past year, IVEVF has traded between a low of $2.28 and a high of $5.75. The stock has gained 152.2% over this period. It is currently 152.2% above its 52-week low.
Inventiva S.A has a market capitalization of $921.96M.
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. The company develops Lanifibranor, a novel pan-peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. It also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. The company was incorporated in 2011 and is headquartered in Daix, France.
Side-by-side comparison against top Healthcare peers.